Primary Site >> Liver Cancer
Gene >> SPINK1
| 1. | |||||||||||
| Journal: | Scand J Clin Lab Invest Suppl. 1991;207:71-3. | ||||||||||
| Title: | Tumor-associated trypsin inhibitor in pancreatic diseases. | ||||||||||
| Author: | Aroasio, E|Piantino, P | ||||||||||
| PMID: | 1723534 | ||||||||||
| 2. | |||||||||||
| Journal: | Int J Cancer. 1993 Nov 11;55(5):728-34. | ||||||||||
| Title: | Specific expression of the pancreatic-secretory-trypsin-inhibitor (PSTI) gene in hepatocellular carcinoma. | ||||||||||
| Author: | Ohmachi, Y|Murata, A|Matsuura, N|Yasuda, T|Yasuda, T|Monden, M|Mori, T|Ogawa, M|Matsubara, K | ||||||||||
| PMID: | 8244568 | ||||||||||
| 3. | |||||||||||
| Journal: | Pancreas. 1996 Apr;12(3):303-7. | ||||||||||
| Title: | Extrapancreatic origin of the pancreatic secretory trypsin inhibitor as an acute-phase reactant. | ||||||||||
| Author: | Jonsson, P|Linder, C|Genell, S|Ohlsson, K | ||||||||||
| PMID: | 8830339 | ||||||||||
| 4. | |||||||||||
| Journal: | J Clin Lab Anal. 1996;10(6):399-402. | ||||||||||
| Title: | Plasma alpha 2-macroglobulin-trypsin complexlike substance (MTLS) in pancreatic disease. | ||||||||||
| Author: | Kato, M|Hayakawa, S|Naruse, S|Kitagawa, M|Nakae, Y|Hayakawa, T | ||||||||||
| PMID: | 8951609 | ||||||||||
| 5. | |||||||||||
| Journal: | Methods Mol Biol. 2006;317:141-55. | ||||||||||
| Title: | Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma. | ||||||||||
| Author: | Kim, Dae-Ghon | ||||||||||
| PMID: | 16264227 | ||||||||||
| 6. | |||||||||||
| Journal: | Eur J Cancer. 2007 Mar;43(4):736-44. | ||||||||||
| Title: | Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma. | ||||||||||
| Author: | Lee, Y-C|Pan, H-W|Peng, S-Y|Lai, P-L|Kuo, W-S|Ou, Y-H|Hsu, H-C | ||||||||||
| PMID: | 17267202 | ||||||||||
| 7. | |||||||||||
| Journal: | Tumour Biol. 2010 Oct;31(5):417-25. | ||||||||||
| Title: | AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues. | ||||||||||
| Author: | Wang, Lin|Huang, Juxiang|Jiang, Minghu|Zheng, Xiguang | ||||||||||
| PMID: | 20532728 | ||||||||||
| 8. | |||||||||||
| Journal: | PLoS One. 2013 Nov 20;8(11):e79826. | ||||||||||
| Title: | Impact of delay to cryopreservation on RNA integrity and genome-wide expression profiles in resected tumor samples. | ||||||||||
| Author: | Caboux, Elodie|Paciencia, Maria|Durand, Geoffroy|Robinot, Nivonirina|Wozniak, Magdalena B|Galateau-Salle, Francoise|Byrnes, Graham|Hainaut, Pierre|Le Calvez-Kelm, Florence | ||||||||||
| PMID: | 24278187 | ||||||||||
| 9. | |||||||||||
| Journal: | Scand J Gastroenterol. 2013 Sep;48(9):1066-73. | ||||||||||
| Title: | Prognostic significance of tumor-associated trypsin inhibitor (TATI) and human chorionic gonadotropin-beta (hCGbeta) in patients with hepatocellular carcinoma. | ||||||||||
| Author: | Lyytinen, Ilana|Lempinen, Marko|Nordin, Arno|Makisalo, Heikki|Stenman, Ulf-Hakan|Isoniemi, Helena | ||||||||||
| PMID: | 23889187 | ||||||||||
| 10. | |||||||||||
| Journal: | Nutr Cancer. 2013;65(4):590-9. | ||||||||||
| Title: | Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells. | ||||||||||
| Author: | Ghasemi, Reza|Ghaffari, Seyed H|Momeny, Majid|Pirouzpanah, Saeed|Yousefi, Mehdi|Malehmir, Mohsen|Alimoghaddam, Kamran|Ghavamzadeh, Ardeshir | ||||||||||
| PMID: | 23659451 | ||||||||||
| 11. | |||||||||||
| Journal: | Zhonghua Gan Zang Bing Za Zhi. 2014 Aug;22(8):625-30. | ||||||||||
| Title: | [Predication analysis of microarray data to determine altered gene profiles in liver carcinoma related to HBV-related cirrhosis]. | ||||||||||
| Author: | Liu, Jianwei|Zhang, Qingqing|Li, Zhenghong|Zhang, Qidi|Qu, Ying|Lu, Lungen|Xu, Mingyi | ||||||||||
| PMID: | 25243966 | ||||||||||
| 12. | |||||||||||
| Journal: | Oncol Res Treat. 2014;37(12):732-8. | ||||||||||
| Title: | Overexpression of tumor-associated trypsin inhibitor (SPINK1/TATI) in hepatitis C-associated hepatocellular carcinoma: potential implications for viral hepatocarcinogenesis. | ||||||||||
| Author: | Hass, Holger G|Jobst, Jurgen|Vogel, Ulrich|Scheurlen, Michael|Nehls, Oliver | ||||||||||
| PMID: | 25531719 | ||||||||||
| 13. | |||||||||||
| Journal: | Med Oncol. 2015 Apr;32(4):96. | ||||||||||
| Title: | Meta-analysis of gene expression profiles indicates genes in spliceosome pathway are up-regulated in hepatocellular carcinoma (HCC). | ||||||||||
| Author: | Xu, Weijin|Huang, Huixing|Yu, Long|Cao, Lihuan | ||||||||||
| PMID: | 25731616 | ||||||||||
| 14. | |||||||||||
| Journal: | Anticancer Res. 2015 Apr;35(4):2021-8. | ||||||||||
| Title: | Gene expression analysis for evaluation of potential biomarkers in hepatocellular carcinoma. | ||||||||||
| Author: | Hass, Holger G|Jobst, Juergen|Scheurlen, Michael|Vogel, Ulrich|Nehls, Oliver | ||||||||||
| PMID: | 25862856 | ||||||||||
| 15. | |||||||||||
| Journal: | Cancer Sci. 2015 Aug;106(8):972-81. | ||||||||||
| Title: | Differential reactivation of fetal/neonatal genes in mouse liver tumors induced in cirrhotic and non-cirrhotic conditions. | ||||||||||
| Author: | Chen, Xi|Yamamoto, Masahiro|Fujii, Kiyonaga|Nagahama, Yasuharu|Ooshio, Takako|Xin, Bing|Okada, Yoko|Furukawa, Hiroyuki|Nishikawa, Yuji | ||||||||||
| PMID: | 26011625 | ||||||||||
| 16. | |||||||||||
| Journal: | Biomed Pharmacother. 2015 May;72:103-8. | ||||||||||
| Title: | FOXP1 and SPINK1 reflect the risk of cirrhosis progression to HCC with HBV infection. | ||||||||||
| Author: | Li, Fei|Liu, Ting|Xiao, Chun-Yang|Yu, Jing-Xia|Lu, Lun-Gen|Xu, Ming-Yi | ||||||||||
| PMID: | 26054682 | ||||||||||
| 17. | |||||||||||
| Journal: | J Dig Dis. 2017 Jun;18(6):349-358. | ||||||||||
| Title: | Serine protease inhibitor Kazal type 1 (SPINK1) downregulates E-cadherin and induces EMT of hepatoma cells to promote hepatocellular carcinoma metastasis via the MEK/ERK signaling pathway. | ||||||||||
| Author: | Ying, Hai Yan|Gong, Chao Jie|Feng, Yi|Jing, Da Dao|Lu, Lun Gen | ||||||||||
| PMID: | 28544403 | ||||||||||
| 18. | |||||||||||
| Journal: | Cell Oncol (Dordr). 2017 Oct;40(5):443-456. | ||||||||||
| Title: | Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/beta-catenin axis in hepatocellular carcinoma. | ||||||||||
| Author: | Shek, Felix H|Luo, Ruibang|Lam, Brian Y H|Sung, Wing Kin|Lam, Tak-Wah|Luk, John M|Leung, Ming Sum|Chan, Kin Tak|Wang, Hector K|Chan, Chung Man|Poon, Ronnie T|Lee, Nikki P | ||||||||||
| PMID: | 28631187 | ||||||||||
| 19. | |||||||||||
| Journal: | Tumour Biol. 2018 Jan;40(1):1010428317752944. | ||||||||||
| Title: | Postoperative CEA is a better prognostic marker than CA19-9, hCGbeta or TATI after resection of colorectal liver metastases. | ||||||||||
| Author: | Peltonen, Reetta|Osterlund, Pia|Lempinen, Marko|Nordin, Arno|Stenman, Ulf-Hakan|Isoniemi, Helena | ||||||||||
| PMID: | 29378497 | ||||||||||